BMY AI forecast — Bristol-Myers Squibb Company
Hedgewing's neural-network ensemble rates BMY a Buy as of .
1-day forecast: $62.49 (+1.83%). Last close $59.56 (-2.92%).
5-day and 20-day price targets, model confidence, and the full AI analysis
are available with a free account.